搜索临床试验以:注射用重组人源化抗PD-1单克隆抗体
总计1077个结果
-
Northwestern UniversityNational Cancer Institute (NCI); Pfizer终止IV 期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 乳腺癌脑转移美国
-
National Cancer Institute (NCI)完全的成人间变性星形细胞瘤 | 成人间变性少突胶质细胞瘤 | 成人巨细胞胶质母细胞瘤 | 成人胶质母细胞瘤 | 成人胶质肉瘤 | 成人混合性胶质瘤 | 复发性成人脑肿瘤美国
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Agenus Inc.; Dutch Cancer Society尚未招聘
-
Innovent Biologics (Suzhou) Co. Ltd.主动,不招人
-
Shanghai Zhongshan HospitalZhejiang Cancer Hospital; Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy... 和其他合作者招聘中
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.招聘中
-
National Cancer Institute (NCI)完全的
-
Sinocelltech Ltd.Tianjin Medical University Cancer Institute and Hospital未知
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Roswell Park Cancer InstituteGlaxoSmithKline主动,不招人
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的乳腺癌 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | HER2 阴性乳腺癌美国
-
Shanghai Fosun Pharmaceutical Industrial Development...招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)Gynecologic Oncology Group完全的
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.完全的
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and Institute招聘中
-
Shanghai Henlius Biotech招聘中
-
EVIVE BiotechnologyPeking University Cancer Hospital & Institute未知复发或难治性 B 细胞淋巴瘤
-
Innovent Biologics (Suzhou) Co. Ltd.终止